Professional Overview

Prof. Dai Wenyan is a senior oncology specialist with more than 20 years of experience in minimally invasive cancer treatment and personalized oncology care. She is widely recognized for her expertise in breast cancer management, particularly in combining advanced medical technology with patient-centered treatment approaches.

Her clinical focus includes minimally invasive therapies, targeted treatment strategies, and immunotherapy evaluation for various types of cancer.

Areas of Expertise

Minimally Invasive Cancer Treatment

Prof. Dai specializes in advanced minimally invasive procedures, including:

• Cryoablation therapy
• Radioactive seed implantation
• Image-guided precision treatment

These techniques are designed to reduce surgical trauma while improving treatment precision and recovery outcomes.

Personalized Oncology & Immunotherapy

She is experienced in:

• Personalized treatment planning
• Targeted therapy strategies
• Immunotherapy efficacy evaluation

Her approach emphasizes evidence-based treatment tailored to each patient’s condition.

Cancer Specialties

Prof. Dai has extensive experience treating:

• Breast cancer
• Lung cancer
• Gastrointestinal cancers
• Gynecological tumors

Career & Leadership

Clinical Experience

With over two decades of oncology experience, Prof. Dai has played an important role in advancing minimally invasive cancer therapies in China.

International Training

She completed advanced clinical training and fellowships at:

• Sun Yat-sen Memorial Hospital
• National University of Singapore Cancer Institute

Professional Appointments

Prof. Dai currently serves as:

• Vice Chair of the GCOG China County Clinical Research Committee (2024–2027)
• Standing Committee Member of the Expert Panel on Personalized Treatment under the Chinese Anti-Cancer Association
• Executive Member of the Particle Therapy Committee under the Chinese Anti-Cancer Association

Achievements at Modern Cancer Hospital Guangzhou

Breast Cancer Center Development

Since leading the breast cancer team in 2016, Prof. Dai and her team have managed more than 20,000 breast cancer cases.

High Breast-Conservation Rate

Under her leadership, the center has achieved a breast-conservation rate of approximately 50–60%, placing it among the leading standards in the field.

Innovative Triple-Therapy Protocol

Prof. Dai pioneered a comprehensive treatment model that integrates:

• Breast-conserving surgery
• Minimally invasive procedures such as cryoablation
• Breast reconstruction and repair

This approach aims to maximize treatment effectiveness while preserving both physical appearance and quality of life.

Academic & Research Contributions

Clinical Guidelines & Standardization

Prof. Dai is actively collaborating with leading medical institutions, including Sun Yat-sen University Cancer Center, to develop consensus guidelines and standardized protocols for breast cancer treatment.

Research & Conferences

In 2024, she presented research at the Chinese Congress on Holistic Integrative Oncology on the topic:
“Frontier Explorations in Immunotherapy Efficacy Evaluation Systems.”

Treatment Philosophy

Prof. Dai Wenyan believes that effective cancer treatment should combine advanced medical technology with compassionate patient care. Her philosophy focuses on delivering scientifically proven, personalized, and humane oncology treatment that supports both physical recovery and emotional well-being.